Infection Prevention & Control (IPC) encompasses the practices, protocols, and products that prevent healthcare-associated infections (HAIs) — infections patients acquire while receiving care. It’s distinct from treating infections: IPC is about stopping them before they occur.
IPC is a defined hospital buyer vertical, with stakeholders and budgets distinct from clinical treatment — relevant to vendors of infection-control products and the facilities that purchase them.
IPC represents a specific buyer segment within hospitals: infection preventionists, quality teams, and supply-chain leaders responsible for reducing HAIs. For vendors of sterilization, disinfection, or PPE products, targeting this vertical means reaching stakeholders focused on prevention rather than treatment.
Distinguishing IPC from infection treatment sharpens targeting — the buyers, budgets, and value propositions differ entirely, and recognizing that is key to effective outreach to facilities.
Infection prevention and control (IPC) is the set of practices and products that prevent healthcare-associated infections — infections patients acquire during care. It includes sterilization, hand hygiene, and surgical-site-infection prevention, and is distinct from treating infections.
IPC focuses on preventing infections before they occur — through sterilization, hygiene, and protocols — while infection treatment addresses infections after they develop. The buyers, budgets, and products differ, which matters for targeting.
Target IPC buyers — infection preventionists, quality leaders, and supply-chain teams — at the facility level, tailoring outreach to prevention goals like reducing HAIs and surgical site infections rather than to clinical treatment.
Surgical site infections (SSIs) are a major category of healthcare-associated infections that IPC programs work to prevent. Reducing SSIs is a core objective of infection prevention and control, making it central to the IPC value proposition.